findmyKOL

Joseph Biundo, MD

Basic profile

Tulane Medical Center

ORCIDNone on fileNPI
RegionMetairie, LA · South CentralSpecialtyRheumatologyFocusRheumatology/Immunology
Last active 2021findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2017Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Joseph Biundo is a Rheumatology/Immunology physician affiliated with Tulane Medical Center. OpenAlex indexes 45 publications with 947 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
45publications

Distinct works indexed by OpenAlex.

947citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

4315 Houma Blvd
Suite 303
Metairie, LA 700062940

Telephone

504-889-5242

Registry record last updated 22 Jul 2010.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2019)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Antiparasitic

    26.4%
    Antimalarial26.4%
    Hydroxychloroquine Sulfate100%
    Part D46 patients
  • Cancer & immunology

    26.4%
    Folate Analog Metabolic Inhibitor26.4%
    Methotrexate100%
    Part D36 patients
  • Musculoskeletal

    23.3%
    Muscle Relaxant10.5%
    Cyclobenzaprine Hcl100%
    Part D<11 patients
    Central alpha-2 Adrenergic Agonist7.8%
    Tizanidine Hcl100%
    Part D12 patients

    + 1 more class in this area

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”